Backed by 25 years of CD83 protein research and formulated for localized cosmetic use in the United States.
A New Topical Approach to Scalp Health
Backed by 25 years of CD83 protein research and formulated for localized cosmetic use in the United States.
CD83 Research and Formulation Development
Mallia Aesthetics is a Germany-based company built on more than 25 years of soluble CD83 (sCD83) research led by immunologist Dr. Alexander Steinkasserer.
This research has explored sCD83’s role in immune signaling, regenerative processes, and hair follicle biology, with over 60 peer-reviewed publications supporting its scientific foundation.
While pharmaceutical development continues internationally, 8T3 Essentials Hair Serum is positioned in the United States as a topical cosmetic formulation designed for localized scalp application.
A Non-Systemic, Scalp-Focused Approach
Mallia 8T3 Essentials Hair Serum is designed to support the biological environment surrounding the hair follicle, with research spanning both inflammation-associated and non-hormonal pathways.
The formulation is intended for topical use, with no expected systemic availability, offering a potential option for patients seeking alternatives to systemic or hormone-based approaches.
Resources for Clinical Partners
Mallia USA supports physician and clinical partners through:
Scientific summaries outlining CD83 research and mechanism
Patient-facing educational materials
Direct communication with the U.S. team for onboarding and support
Request Clinical Information
Connect with Mallia USA to learn more about 8T3 Essentials Hair Serum, including scientific background, patient positioning and integration into your practice.
